Regulation of innate antiviral responses by the DNA-binding transcriptional repressor complex CIC-ATXN1/L

DNA 结合转录抑制复合物 CIC-ATXN1/L 对先天抗病毒反应的调节

基本信息

  • 批准号:
    10874145
  • 负责人:
  • 金额:
    $ 7.78万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-08-01 至 2027-07-31
  • 项目状态:
    未结题

项目摘要

Abstract Interferon (IFN) and IFN stimulated genes (ISGs) are a critical component of innate immune responses that help in the early control of viral infections. Transcriptional upregulation of IFN and ISGs is tightly controlled through negative regulators under basal conditions to maintain homeostasis, as aberrant expression of IFN and ISGs can promote diseases like chronic viral infection, cancers, neurodegeneration, and diabetes. Through a genome- wide CRISPR/Cas9 screen to identify proviral host factors and regulators of innate immunity, we identified Capicua (CIC) as a novel regulator of innate immune responses, as CIC knockout (CIC KO) cells demonstrated transcriptional upregulation of IFN and ISGs under basal conditions and showed restricted replication of different RNA viruses. Based on studies in drosophila and cancer models, CIC, a highly conserved DNA-binding transcriptional repressor, binds to a specific octameric sequence (CIC binding site or CBS) near target genes and constitutively represses gene transcription. Through promoter motif analysis of ISGs upregulated in CIC KO cells identified by RNA-Seq, we observed the presence of CBS motifs in several, but not all, upregulated ISGs, including RIG-I, MDA-5, IRF3/7/9, IFNβ, IFNγ, IFIT1, TRIM22, MX1, and ISG15. Preliminary Assay for Transposase-Accessible Chromatin (ATAC)-Seq analysis confirmed increased chromatin accessibility near the putative CBS containing IFIT1 and TRIM22 promoters in CIC KO as compared to control A549 cells. In addition, we validated direct CIC binding to IFNβ and ISG promoters (STAT1, IFIT1,TRIM22) by chromatin immunoprecipitation-qPCR (ChIP-qPCR) analysis. Moreover, the CIC-ATXN1/L co-repressor complex is rapidly degraded during influenza virus infection, suggesting that degradation of the CIC-ATXN1/L complex may be an integral part of the innate immune response pathway. Importantly, the innate immune regulatory function of the Cic-Atxn1/l co-repressor complex is conserved in the murine model. Based on these findings, we propose a novel model for the transcriptional regulation of IFN and ISGs: under basal conditions, the CIC-ATXN1/L co- repressor complex binds to CBS and represses ISG transcription; however, virus-induced proteasomal degradation of CIC-ATXN1/L relieves these target genes from active repression, thereby allowing for robust transcription through IRFs and STATs. The goal of this proposal is to gain mechanistic insights into the transcriptional regulation of IFN and ISG promoters by the CIC-ATXN1/L co-repressor complex, ultimately providing a new paradigm for the regulation of cell autonomous antiviral responses. PHS 398/2590 (Rev. 06/09) Page Continuation Format Page
摘要 干扰素(IFN)和IFN刺激基因(ISG)是先天免疫反应的关键组成部分, 病毒感染的早期控制。IFN和ISG的转录上调通过以下途径被严格控制: 在基础条件下维持稳态的负调节因子,如IFN和ISGs的异常表达 可以促进慢性病毒感染、癌症、神经退化和糖尿病等疾病。通过基因组- 广泛的CRISPR/Cas9筛选,以确定先天免疫的前病毒宿主因子和调节因子,我们确定了 Capicua(CIC)作为先天免疫应答的新型调节剂,如CIC敲除(CIC KO)细胞所示 在基础条件下,IFN和ISG的转录上调,并显示不同的限制性复制 RNA病毒。基于在果蝇和癌症模型中的研究,CIC,一种高度保守的DNA结合蛋白, 转录阻遏物,结合到靶基因附近的特定八聚体序列(CIC结合位点或CBS 并组成性抑制基因转录。通过CIC KO中上调的ISG的启动子基序分析 通过RNA-Seq鉴定的细胞中,我们观察到CBS基序在几个但不是全部上调的ISG中的存在, 包括RIG-I、MDA-5、IRF 3/7/9、IFNβ、IFNγ、IFIT 1、TRIM 22、MX 1和ISG 15。初步试验 转座酶可降解染色质(ATAC)-Seq分析证实了在细胞核附近增加的染色质可及性。 与对照A549细胞相比,CIC KO中含有IFIT 1和TRIM 22启动子的推定CBS。此外,本发明还提供了一种方法, 我们验证了CIC与IFNβ和ISG启动子(STAT 1,IFIT 1,TRIM 22)的直接结合, 免疫沉淀-qPCR(ChIP-qPCR)分析。此外,CIC-ATXN 1/L共阻遏物复合物被快速地 在流感病毒感染期间降解,这表明CIC-ATXN 1/L复合物的降解可能是流感病毒感染的一个原因。 先天免疫反应途径的组成部分。重要的是,先天性免疫调节功能, Cic-Atxn 1/l共阻遏物复合物在鼠模型中是保守的。基于这些发现,我们提出了一个 IFN和ISGs转录调控的新模型:在基础条件下,CIC-ATXN 1/L共- 阻遏物复合物与CBS结合并阻遏ISG转录;然而,病毒诱导的蛋白酶体 CIC-ATXN 1/L的降解解除了这些靶基因的活性抑制,从而允许稳健的表达。 通过IRFs和STAT转录。本提案的目标是获得对 CIC-ATXN 1/L共阻遏物复合物对IFN和ISG启动子的转录调控,最终 为调节细胞自主抗病毒反应提供了新的范例。 PHS 398/2590(Rev.06/09)

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Balaji Manicassamy其他文献

Balaji Manicassamy的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Balaji Manicassamy', 18)}}的其他基金

Regulation of innate antiviral responses by the DNA-binding transcriptional repressor complex CIC-ATXN1/L
DNA 结合转录抑制复合物 CIC-ATXN1/L 对先天抗病毒反应的调节
  • 批准号:
    10671677
  • 财政年份:
    2022
  • 资助金额:
    $ 7.78万
  • 项目类别:
Regulation of innate antiviral responses by the DNA-binding transcriptional repressor complex CIC-ATXN1/L
DNA 结合转录抑制复合物 CIC-ATXN1/L 对先天抗病毒反应的调节
  • 批准号:
    10539709
  • 财政年份:
    2022
  • 资助金额:
    $ 7.78万
  • 项目类别:
ENDOTHELIAL CELL TROPISM IN THE PATHOGENESIS AND HOST RESPONSE AGAINST INFLUENZA VIRUSES - RESUBMISSION 01
发病机制中的内皮细胞趋向性和宿主对流感病毒的反应 - 重新提交 01
  • 批准号:
    9769437
  • 财政年份:
    2017
  • 资助金额:
    $ 7.78万
  • 项目类别:
Endothelial cell tropism in the pathogenesis and host response against influenza viruses - Resubmission 01
流感病毒发病机制和宿主反应中的内皮细胞向性 - 重新提交 01
  • 批准号:
    10303023
  • 财政年份:
    2017
  • 资助金额:
    $ 7.78万
  • 项目类别:
Modulation of Influenza Virus Replication and Fitness by Adenosine Deaminases
腺苷脱氨酶对流感病毒复制和适应性的调节
  • 批准号:
    9083899
  • 财政年份:
    2016
  • 资助金额:
    $ 7.78万
  • 项目类别:
Modulation of Influenza Virus Replication and Fitness by Adenosine Deaminases
腺苷脱氨酶对流感病毒复制和适应性的调节
  • 批准号:
    9472173
  • 财政年份:
    2016
  • 资助金额:
    $ 7.78万
  • 项目类别:
Modulation of Influenza Virus Replication and Fitness by Adenosine Deaminases
腺苷脱氨酶对流感病毒复制和适应性的调节
  • 批准号:
    9925203
  • 财政年份:
    2016
  • 资助金额:
    $ 7.78万
  • 项目类别:
Pan-Influenza virus inhibitors: Small molecules that disrupt host ADAR1-viral NS1 interactions
泛流感病毒抑制剂:破坏宿主 ADAR1-病毒 NS1 相互作用的小分子
  • 批准号:
    9086232
  • 财政年份:
    2015
  • 资助金额:
    $ 7.78万
  • 项目类别:
Pan-Influenza virus inhibitors: Small molecules that disrupt host ADAR1-viral NS1 interactions
泛流感病毒抑制剂:破坏宿主 ADAR1-病毒 NS1 相互作用的小分子
  • 批准号:
    8956083
  • 财政年份:
    2015
  • 资助金额:
    $ 7.78万
  • 项目类别:
Modulation of Influenza Virus Replication and Fitness by Adenosine Deaminases
腺苷脱氨酶对流感病毒复制和适应性的调节
  • 批准号:
    9090008
  • 财政年份:
    2015
  • 资助金额:
    $ 7.78万
  • 项目类别:

相似海外基金

Regulation of RIG-I mediated antiviral response upon influenza A virus infection
RIG-I介导的甲型流感病毒感染抗病毒反应的调节
  • 批准号:
    494286
  • 财政年份:
    2023
  • 资助金额:
    $ 7.78万
  • 项目类别:
    Operating Grants
Activation of the DNA-PK-dependent antiviral response as a novel cancer immunotherapy
激活 DNA-PK 依赖性抗病毒反应作为一种新型癌症免疫疗法
  • 批准号:
    10364056
  • 财政年份:
    2022
  • 资助金额:
    $ 7.78万
  • 项目类别:
ADAR1-mediated antiviral response in Zika virus (ZIKV) infection
ADAR1 介导的寨卡病毒 (ZIKV) 感染抗病毒反应
  • 批准号:
    10621913
  • 财政年份:
    2022
  • 资助金额:
    $ 7.78万
  • 项目类别:
Activation of the DNA-PK-dependent antiviral response as a novel cancer immunotherapy
激活 DNA-PK 依赖性抗病毒反应作为一种新型癌症免疫疗法
  • 批准号:
    10553146
  • 财政年份:
    2022
  • 资助金额:
    $ 7.78万
  • 项目类别:
ADAR1-mediated antiviral response in Zika virus (ZIKV) infection
ADAR1 介导的寨卡病毒 (ZIKV) 感染抗病毒反应
  • 批准号:
    10373627
  • 财政年份:
    2022
  • 资助金额:
    $ 7.78万
  • 项目类别:
Mechanisms of IgE-mediated regulation of monocyte antiviral response pathways
IgE介导的单核细胞抗病毒反应途径的调节机制
  • 批准号:
    10640247
  • 财政年份:
    2021
  • 资助金额:
    $ 7.78万
  • 项目类别:
Interplay between AMPK and Hippo Signaling Regulates Ocular Antiviral Response to Zika virus infection
AMPK 和 Hippo 信号传导之间的相互作用调节眼部对寨卡病毒感染的抗病毒反应
  • 批准号:
    10322026
  • 财政年份:
    2021
  • 资助金额:
    $ 7.78万
  • 项目类别:
Mechanisms of IgE-mediated regulation of monocyte antiviral response pathways
IgE 介导的单核细胞抗病毒反应途径调节机制
  • 批准号:
    10438876
  • 财政年份:
    2021
  • 资助金额:
    $ 7.78万
  • 项目类别:
Antiviral response coupled with transposon derepression in Alzheimer's disease and aging
抗病毒反应与转座子去抑制在阿尔茨海默病和衰老中的作用
  • 批准号:
    10629440
  • 财政年份:
    2021
  • 资助金额:
    $ 7.78万
  • 项目类别:
Epigenetic Control of Mucosal IRF1/IFN-III Antiviral Response by Enhancer-like Promoter and its Coding lncRNA
增强子样启动子及其编码lncRNA对粘膜IRF1/IFN-III抗病毒反应的表观遗传控制
  • 批准号:
    10373575
  • 财政年份:
    2021
  • 资助金额:
    $ 7.78万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了